Chapter MMU
At risk

Medication management and use

Assesses hospital governance, standardized clinical protocols, staff adherence, and documented evidentiary compliance for medication management and use.

Standard Weight: 10x•Total Requirements: 22•Open Findings: 10
0%Readiness

Trend Direction

down (-3%)

Identified compliance findings in MMU (10)

critical
F-0142
Open

Independent double-check for high-alert medications not consistently performed at administration; self-assessment claimed 94% but evidence supports 71% and observed practice 68%.

MMU.3
Pharmacy
Dr. Fatima Al-Mansoor
high
F-0228
Open

Evidence gap identified for MMU.4 during mock surveyor; requires documented remediation. (demonstration)

MMU.4
Infection Prevention
Dr. Priya Sharma
medium
F-0234
Open

Evidence gap identified for MMU.6 during live field capture; requires documented remediation. (demonstration)

MMU.6
Emergency
Dr. Fatima Al-Mansoor
high
F-0238
awaiting-verification

Evidence gap identified for MMU.1 during mock surveyor; requires documented remediation. (demonstration)

MMU.1
HR
Dr. Carlos Mendez
critical
F-0240
awaiting-verification

Evidence gap identified for MMU.6 during document analysis; requires documented remediation. (demonstration)

MMU.6
Laboratory
Dr. Kenji Tanaka
medium
F-0242
Open

Evidence gap identified for MMU.7 during learner evaluation; requires documented remediation. (demonstration)

MMU.7
Infection Prevention
Dr. Lucas Dubois
high
F-0244
In progress

Evidence gap identified for MMU.5 during live field capture; requires documented remediation. (demonstration)

MMU.5
Operating Theatres
Dr. Priya Sharma
medium
F-0248
Open

Evidence gap identified for MMU.6 during mock surveyor; requires documented remediation. (demonstration)

MMU.6
Emergency
Dr. Elena Rostova
low
F-0253
Open

Evidence gap identified for MMU.1 during mock surveyor; requires documented remediation. (demonstration)

MMU.1
ICU
Dr. Lucas Dubois
medium
F-0255
awaiting-verification

Evidence gap identified for MMU.4 during document analysis; requires documented remediation. (demonstration)

MMU.4
Paediatrics
Dr. Elena Rostova

Requirements & Measurable Elements

22 total requirements
Requirement
Standard text (paraphrased)
Criticality
Measurable Elements
Status
MMU.1

Medication use organised and governed by a responsible pharmacy structure (paraphrased)

policyorg-chart
high
4 of 5 met70%
Partial
MMU.3

Medication storage, labelling and independent double-check before administration (paraphrased)

policytrainingobservationaudit
critical
4 of 6 met61%
Gap
MMU.4

Prescribing and ordering governed by defined, authorised processes (paraphrased)

policyaudit
high
2 of 3 met66%
Partial
MMU.5

Preparation and dispensing performed in a clean, controlled manner (paraphrased)

policyobservation
high
3 of 5 met68%
Partial
MMU.6

Administration verified against order with independent second check for high-alert drugs (paraphrased)

trainingobservationaudit
critical
4 of 6 met59%
Gap
MMU.7

Medication effects monitored and adverse events reported (paraphrased)

policyreports
medium
2 of 3 met74%
Partial
MMU.8

Medication management and use — control 8: documented process, responsible owner and evidence of practice (paraphrased)

policyaudit
medium
2 of 4 met56%
Gap
MMU.9

Medication management and use — control 9: documented process, responsible owner and evidence of practice (paraphrased)

policyaudit
high
2 of 3 met51%
Gap
MMU.10

Medication management and use — control 10: documented process, responsible owner and evidence of practice (paraphrased)

policyaudit
medium
4 of 5 met72%
Partial
MMU.11

Medication management and use — control 11: documented process, responsible owner and evidence of practice (paraphrased)

policyaudit
medium
2 of 4 met54%
Gap
MMU.12

Medication management and use — control 12: documented process, responsible owner and evidence of practice (paraphrased)

policyaudit
medium
3 of 5 met68%
Partial
MMU.13

Medication management and use — control 13: documented process, responsible owner and evidence of practice (paraphrased)

policyaudit
medium
3 of 6 met54%
Gap
MMU.14

Medication management and use — control 14: documented process, responsible owner and evidence of practice (paraphrased)

policyaudit
critical
2 of 3 met65%
Partial
MMU.15

Medication management and use — control 15: documented process, responsible owner and evidence of practice (paraphrased)

policyaudit
medium
2 of 4 met47%
Gap
MMU.16

Medication management and use — control 16: documented process, responsible owner and evidence of practice (paraphrased)

policyaudit
medium
2 of 3 met63%
Gap
MMU.17

Medication management and use — control 17: documented process, responsible owner and evidence of practice (paraphrased)

policyaudit
low
2 of 4 met51%
Gap
MMU.18

Medication management and use — control 18: documented process, responsible owner and evidence of practice (paraphrased)

policyaudit
high
2 of 3 met65%
Partial
MMU.19

Medication management and use — control 19: documented process, responsible owner and evidence of practice (paraphrased)

policyaudit
low
5 of 6 met77%
Partial
MMU.20

Medication management and use — control 20: documented process, responsible owner and evidence of practice (paraphrased)

policyaudit
critical
3 of 4 met71%
Partial
MMU.21

Medication management and use — control 21: documented process, responsible owner and evidence of practice (paraphrased)

policyaudit
low
2 of 3 met73%
Partial
MMU.22

Medication management and use — control 22: documented process, responsible owner and evidence of practice (paraphrased)

policyaudit
low
4 of 6 met71%
Partial
MMU.23

Medication management and use — control 23: documented process, responsible owner and evidence of practice (paraphrased)

policyaudit
medium
3 of 4 met73%
Partial

Demonstration output from synthetic data. This is decision support for your quality team, not an accreditation determination.